Chronic nicotine consumption does not influence 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone-induced lung tumorigenesis

Cancer Prevention Research

Volumn 4, Issue 11, 2011, Pages 1752-1760

  Murphy, Sharon E ^a,b   Von Weymarn, Linda B ^a,b   Schutten, Melissa M ^a,b,c   Kassie, Fekadu ^a,b   Modiano, Jaime F ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYCOTININE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 6 O METHYLGUANINE; COTININE; CYTOCHROME P450 2A5; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; FEMALE; FLUID INTAKE; LIVER MICROSOME METABOLISM; LONG TERM EXPOSURE; LUNG ADENOMA; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG TUMOR; MOUSE; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PRIORITY JOURNAL; TUMOR CLASSIFICATION; TUMOR GROWTH; TUMOR VOLUME;

ADENOMA; ANIMALS; CARCINOGENS; CELLS, CULTURED; DRINKING WATER; FEMALE; GUANINE; HUMANS; LIVER; LUNG; LUNG NEOPLASMS; MICE; MICE, INBRED A; NICOTINE; NITROSAMINES;

EID: 81555210890     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0366     Document Type: Article

References (45)

1. CDC. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morb Mortal Wkly Rep 2008;57:1226-8.
2. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36.
3. Apelberg BJ, Onicescu G, Avila-Tang E, Samet JM. Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States. Am J Public Health 2010;100:341-8.
4. Spindel ER. Is nicotine the estrogen of lung cancer? Am J Respir Crit Care Med 2009;179:1081-2.
5. Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001;7:833-9. (Pubitemid 32691639)
6. Oloris SC, Frazer-Abel AA, Jubala CM, Fosmire SP, Helm KM, Robinson SR, et al. Nicotine-mediated signals modulate cell death and survival of T lymphocytes. Toxicol Appl Pharmacol 2010;242:299-309.
7. Improgo MR, Scofield MD, Tapper AR, Gardner PD. The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer. Prog Neurobiol 2010;92:212-26.
8. Hecht SS. Tobacco carcinogens, their biomarkers, and tobaccoinduced cancer. Nature Rev Cancer 2003;3:733-44. (Pubitemid 37328812)
9. Waldum HL, Nilsen OG, Nilsen T, Rorvik H, Syversen V, Sanvik AK, et al. Long-term effects of inhaled nicotine. Life Sci 1996;58:1339-46. (Pubitemid 26109597)
10. Schuller HM, McGavin MD, Orloff M, Riechert A, Porter B. Simultaneous exposure to nicotine and hyperoxia causes tumors in hamsters. Lab Invest 1995;73:448-56.
11. Jarzynka MJ, Guo P, Bar-Joseph I, Hu B, Cheng SY. Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis. Int J Oncol 2006;28:337-44.
12. Davis R, Rizwani W, Banerjee S, Kovacs M, Haura E, Coppola D, et al. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One 2009;4:e7524.
13. Al Wadei HA, Plummer HK III, Schuller HM. Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gammaaminobutyric acid. Carcinogenesis 2009;30:506-11.
14. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008;40:616-22. (Pubitemid 351601203)
15. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633-7. (Pubitemid 351483367)
16. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008;452:638-42. (Pubitemid 351483366)
17. Spitz MR, Amos CI, Dong Q, Lin J, Wu X. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 2008;100:1552-6.
18. Kuehn BM. FDA considering data on long-term use of nicotine replacement therapy products. JAMA 2010;304:2580.
19. Galvan A, Dragani TA. Nicotine dependence may link the 15q25 locus to lung cancer risk. Carcinogenesis 2010;31:331-3.
20. Murray RP, Connett JE, Zapawa LM. Does nicotine replacement therapy cause cancer? Evidence from the Lung Health Study. Nicotine Tob Res 2009;11:1076-82.
21. Konishi H, Wu J, Cooke JP. Chronic exposure to nicotine impairs cholinergic angiogenesis. Vasc Med 2010;15:47-54.
22. Brown B, Avalos J, Lee C, Doolittle D. The effect of tobacco smoke, nicotine, and cotinine on the mutagenicity of 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanol (NNAL). Mutat Res 2001;494:21-9. (Pubitemid 32566279)
23. Richter E, Tricker AR. Nicotine inhibits the metabolic activation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats. Carcinogenesis 1994;15:1061-4. (Pubitemid 24156911)
24. Richter E, Tricker AR. Effect of nicotine, cotinine and phenethyl isothiocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in the Syrian golden hamster. Toxicology 2002;179:95-103. (Pubitemid 35245467)
25. Hukkanen J, Jacob P III, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005;57:79-115. (Pubitemid 40283970)
26. Murphy SE, Raulinaitis V, Brown KM. Nicotine 50-oxidation and methyl oxidation by P450 2A enzymes. Drug Metab Dispos 2005;13:1166-73. (Pubitemid 41043760)
27. von Weymarn LB, Brown KM, Murphy SE. Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism. J Pharmacol Exp Ther 2006;316:295-303. (Pubitemid 41832609)
28. Jalas JR, Hecht SS, Murphy SE. Cytochrome P450 enzymes as catalysts of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific carcinogen. Chem Res Toxicol 2005;18:95-110. (Pubitemid 40267791)
29. Zhang X, D'Agostino J, Wu H, Zhang QY, von Weymarn L, Murphy SE, et al. CYP2A13: variable expression and role in human lung microsomal metabolic activation of the tobacco-specific carcinogen 4- (methylnitrosamino)-1-(3- pyridyl)-1-butanone. J Pharmacol Exp Ther 2007;323:570-8. (Pubitemid 350005129)
30. Malkinson AM. Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung. Lung Cancer 2001;32:265-79. (Pubitemid 32487687)
31. Hecht SS. Biochemistry, biology, and carcinogenicity of tobaccospecific N-nitrosamines. Chem Res Toxicol 1998;11:559-603.
32. Hecht SS, Jordan KG, Choi CI, Trushin N. Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. Carcinogenesis 1990;11:1017-20. (Pubitemid 20207359)
33. Peterson LA, Hecht SS. O6-Methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res 1991;51:5557-64.
34. Weng Y, Fang C, Turesky RJ, Behr M, Kaminsky LS, Ding X. Determination of the role of target tissue metabolismin lung carcinogenesis using conditional cytochrome P450 reductase-null mice. Cancer Res 2007;67:7825-32. (Pubitemid 47281377)
35. Kassie F, Anderson LB, Scherber R, Yu N, Lahti D, Upadhyaya P, et al. Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo(a)pyrene-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levels. Cancer Res 2007;67:6502-11. (Pubitemid 47037536)
36. Hecht SS, Morse MA, Amin S, Stoner GD, Jordan KG, Choi CI, et al. Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis 1989;10:1901-4. (Pubitemid 19244867)
37. Nikitin AY, Alcaraz A, Anver MR, Bronson RT, Cardiff RD, Dixon D, et al. Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res 2004;64:2307-16. (Pubitemid 38523879)
38. Wong HL, Murphy SE, Wang M, Hecht SS. Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3. Carcinogenesis 2003;24:291-300. (Pubitemid 36267099)
39. von Weymarn LB, Felicia ND, Ding X, Murphy SE. N-Nitrosobenzyl- methylamine α-hydroxylation and coumarin 7-hydroxylation by rat esophageal microsomes and cytochrome P450 2A3 and 2A6 enzymes. Chem Res Toxicol 1999;12:1254-61. (Pubitemid 30013537)
40. Upadhyaya P, Lindgren BR, Hecht SS. Comparative levels of O6-methylguanine, pyridyloxobutyl-, and pyridylhydroxybutyl-DNA adducts in lung and liver of rats treated chronically with the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Drug Metab Dispos. 2009;37:1147-51.
41. Bloom AJ, Hinrichs AL, Wang JC, von Weymarn LB, Bierut LJ, Goate A, et al. The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European Americans. Pharmacogenet Genomics 2011;21:403-16.
42. Maier CR, Hollander C, Dogan I, Dennis PA. Nicotine does not enhance lung tumorigenesis in K-Ras-driven mouse models of lung cancer. Cancer Prev Res 2011;4:1743-51.
43. Raunio H, Pokela N, Puhakainen K, Rahnasto M, Mauriala T, Auriola S, et al. Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo. Xenobiotica 2008;38:34-47.
44. Siu EC, Tyndale RF. Characterization and comparison of nicotine and cotinine metabolism in vitro and in vivo in DBA/2 and C57BL/6 mice. Mol Pharmacol 2007;71:826-34. (Pubitemid 46294094)
45. Memmott RM, Mercado JR, Maier CR, Kawabata S, Fox SD, Dennis PA. Metformin prevents tobacco carcinogen-induced lung tumorigenesis. Cancer Prev Res 2010;3:1066-76.